Although there were some differences in the levels of RIPK1, RIPK3, and MLKL protein in the UREA soluble fraction, determined by western blotting, these were not significantly different between controls and AD, mainly due to the high degree of heterogeneity in the AD cases (Fig. 1b, c). The gene discussed is MLKL; the disease is Alzheimer disease.